Evaluation of the topical cyclosporin-A therapy in persistent vernal keratoconjunctivitis patients
PDF
Cite
Share
Request
Research Article
VOLUME: 6 ISSUE: 1
P: 25 - 27
2016

Evaluation of the topical cyclosporin-A therapy in persistent vernal keratoconjunctivitis patients

J Dr Behcet Uz Child Hosp 2016;6(1):25-27
1. Ozel Deniz Hospital
2. Batigöz Eye Health Center
No information available.
No information available
Received Date: 2015-11-12T09:32:18
Accepted Date: 2016-04-15T16:16:47
PDF
Cite
Share
Request

Abstract

INTRODUCTION

Persistent Vernal keratoconjunctivitis is a chronicle and inflammatory and sight-threating disease of the eyelid and anterior segment of the eye. Topical Cyclosprine-A is an important alternative in these situations.

METHODS

Seven male patients between the age of 8-17 are evaluated retrospective in our clinic. The subjective complaints, the course of the disease and the response to the therapy were recorded.

RESULTS

The complaints and the symptoms decreased one week later. Three months later, there were no complaints in any patient and the cobblestone formation disappeared and converted to follicular hypertrophy.The patients are still under follow-up in our clinic

DISCUSSION AND CONCLUSION

Our belief is that topical Cyclosporine-A is a well-tolerated and reliable option in patients with persistent vernal keratoconjunctivitis. Further investigations are necessary to determine its effect on relapses and how long it can be supress the disorder.

Keywords:
Cyclosporin A, Vernal keratokonjunctivitis, ocular inflammation